In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.
Curaleaf (CNSX: CURA) reported strong 2018 numbers, clearly indicating they are set to dominate U.S. marijuana in 2019. Is the stock price is justified?
This week, the President of Grizzle – Thomas George – discusses the recent deal between Canopy (WEED) and Martha Stewart for CBD products and the latest numbers from Colorado on cannabis tourism.